UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How and when I do allogeneic transplant in CLL

Blood, 2018-07, Vol.132 (1), p.31-39

Gribben, John G.

2018

Volltextzugriff (PDF)

Targeting the methylome to improve CLL outcome

Blood, 2023-07, Vol.142 (1), p.4-6

Gribben, John G.

2023

Volltextzugriff (PDF)

Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia

British journal of haematology, 2020-03, Vol.188 (6), p.844-851

Gribben, John G.

2020

Volltextzugriff (PDF)

To start and stop or just keep going?

Blood, 2021-09, Vol.138 (10), p.819-820

Gribben, John G.

2021

Volltextzugriff (PDF)

Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?

British journal of haematology, 2020-05, Vol.189 (4), p.603-604

Gribben, John G.

2020

Volltextzugriff (PDF)

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Blood, 2015-07, Vol.126 (2), p.203-211

2015

Volltextzugriff (PDF)

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

British journal of haematology, 2018-03, Vol.180 (5), p.666-679

2018

Volltextzugriff (PDF)

Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer

Blood, 2012-08, Vol.120 (7), p.1412-1421

2012

Volltextzugriff (PDF)

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2019-01, Vol.20 (1), p.43-56

2019

Volltextzugriff (PDF)

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

Haematologica (Roma), 2022-09, Vol.107 (9), p.2108-2120

2022

Volltextzugriff (PDF)

Bone marrow niches in haematological malignancies

Nature reviews. Cancer, 2020-05, Vol.20 (5), p.285-298

2020

Volltextzugriff (PDF)

Molecular Hematology

Drew Provan, John Gribben / Drew Provan, John Gribben

Fourth edition, 2019

Volltextzugriff (PDF)

Update on Therapy of Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2011-02, Vol.29 (5), p.544-550

2011

Volltextzugriff (PDF)

No longer too exhausted to run

Blood, 2018-08, Vol.132 (5), p.464-465

Gribben, John G.

2018

Volltextzugriff (PDF)

The role of BTK inhibitors on the tumor microenvironment in CLL

Leukemia & lymphoma, 2022-07, Vol.63 (9), p.2023-2032

2022

Volltextzugriff (PDF)

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

Blood, 2013-02, Vol.121 (9), p.1612-1621

2013

Volltextzugriff (PDF)

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells

PloS one, 2012-02, Vol.7 (2), p.e32584-e32584

2012

Volltextzugriff (PDF)

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Blood, 2019-06, Vol.133 (26), p.2765-2775

2019

Volltextzugriff (PDF)

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.1121-1132

2013

Volltextzugriff (PDF)

Restoring leukemia cell function from the inside out

Blood, 2017-06, Vol.129 (24), p.3137-3138

Gribben, John G.

2017

Volltextzugriff (PDF)

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion

Haematologica (Roma), 2023-04, Vol.108 (4), p.1068-1082

2023

Volltextzugriff (PDF)

Chronic lymphocytic leukemia cells induce defective LFA-1–directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide

Blood, 2013-04, Vol.121 (14), p.2704-2714

2013

Volltextzugriff (PDF)

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

Blood, 2013-10, Vol.122 (16), p.2856-2863

2013

Volltextzugriff (PDF)

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Current cancer drug targets, 2016-10, Vol.16 (8), p.689-700

2016

Volltextzugriff (PDF)

1 – 25 von 823

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

SpracheJapanisch

Publikationsformmagazinearticle

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(663)
Mit Volltextzugriff
(697)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(353)
Life Sciences & Biomedicine
(330)
Humans
(312)
Hematology
(224)
Biological And Medical Sciences
(100)
Oncology
(98)
Male
(96)
Female
(95)
Medical Sciences
(90)
Middle Aged
(81)
Adult
(70)
Hematologic And Hematopoietic Diseases
(64)
Aged
(58)
Animals
(58)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(58)
Leukemia
(48)
Chronic Lymphocytic Leukemia
(45)
Prognosis
(45)
Treatment Outcome
(45)
Mice
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

How and when I do allogeneic transplant in CLL

Targeting the methylome to improve CLL outcome

Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia

To start and stop or just keep going?

Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

Bone marrow niches in haematological malignancies

Molecular Hematology

Update on Therapy of Chronic Lymphocytic Leukemia

No longer too exhausted to run

The role of BTK inhibitors on the tumor microenvironment in CLL

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

Restoring leukemia cell function from the inside out

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion

Chronic lymphocytic leukemia cells induce defective LFA-1–directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription

Aktive Filter

Suchergebnisse filtern